FDA Rules Out Thigh Fracture Link with Bisphosphonate, Including Medications such as Merck & Co., Inc.'s Fosamax

Reuters -- U.S. regulators said on Wednesday they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc's (MRK.N) Fosamax and certain thigh bone fractures.